USA – Samsung Electronics’ US-based subsidiary Boston Imaging has unveiled a new ultrasound system called V7 with an aim to provide enhanced patient and user experience.

Recently, the ultrasound system secured FDA 510(k) clearance from the US Food and Drug Administration (FDA).

According to Boston Imaging, V7 is built to handle difficult clinical cases with accuracy and precision in a busy ultrasound setting as well.

Boston Imaging head David Legg said: “There is a continued demand on imaging professionals to deliver high-quality results in an efficient amount of time, without compromising patient care.

“We’re proud to help address this by supplying one more solution that helps make clinical assessments effortless and treatment precise.”

The new ultrasound system from the Samsung subsidiary is based on Crystal Architecture to offer improved image clarity and penetration.

It combines beamforming (CrystalBeam), sophisticated image processing (CrystalLive), and advanced S-Vue Single Crystal Transducers to produce images that are clear, uniform, and high resolution.

The V7 ultrasound system is equipped with various Intelligent Assist features that allow it to be used in general imaging as well as women’s health ultrasound cases.

It has an automated 2D Follicle measurement tool that identifies and measures follicle size based on the 2D image. This lets the system generate information about the status of follicles during gynecology examinations.

Boston Imaging has installed an AutoIMT screening tool on V7 to assess the potential risk of patients for cardiovascular disease.

V7 is built to handle difficult clinical cases with accuracy and precision in a busy ultrasound setting as well.

It also includes an S-Shearwave Imaging tool, which offers non-invasive assessment and documentation of tissue stiffness for clinical applications.

Additionally, V7 incorporates UterineAssist artificial intelligence technology that measures the uterus’ size and shape automatically to help detect any uterine-related abnormalities.

Furthermore, the system has an E-Cervix elastography technology that provides an efficient semi-quantitative evaluation of stiffness in the cervical canal.

Additionally, the ultrasound system incorporates artificial intelligence (AI)-based UterineAssist technology that measures the uterus’ size and shapes automatically to help spot any abnormalities.

V7 is also integrated with the E-Cervix elastography technology to offer an efficient semi-quantitative evaluation of stiffness in the cervical canal, said Boston Imaging.

In April this year, Boston Imaging launched a new mobile digital radiography device called the GM85 Fit.

The modality offers a variety of benefits including an ability to take up to 550 exposures during 11 hours of use without additional charging, an ultralight design to promote easy mobility, and a lightweight detector, which facilitates patient positioning, according to Boston Imaging.

Other highlights for the GM85 Fit include low noise levels and an ability to recharge within three to four hours.

A new configuration of the AccE GM85, the GM85 Fit has imaging features such as S-Enhance, which aids in the detection of foreign bodies in the abdomen, chest, and lumbar spine, and SimGrid, which offers improved quality of non-grid images that are comparable to the quality of grid images.

For chest X-rays, the GM85 Fit has a Bone Suppression feature that enables radiologists to suppress the appearance of bones in order to bolster soft tissue clarity.

Liked this article? Sign up to receive our regular email newsletters, focused on Africa and World’s healthcare industry, directly into your inbox. SUBSCRIBE HERE